SCHEMBL369808

SCHEMBL369808

c1cncc(-c2cn[nH]c2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.63
AKT2 P31751 1/20 0.63
CYP2A6 P11509 8/20 0.62
CYP3A4 P08684 4/20 0.62
ALDH1A1 P00352 3/20 0.62
CYP1A2 P05177 2/20 0.62
PIM1 P11309 1/20 0.57
MAPK1 P28482 1/20 0.57
METAP2 P50579 1/20 0.53
SIRT3 Q9NTG7 1/20 0.53
CYP2B6 P20813 3/20 0.50
CYP2E1 P05181 2/20 0.50
AURKA O14965 1/20 0.49
TTK P33981 1/20 0.49
AURKB Q96GD4 1/20 0.49
INCENP Q9NQS7 1/20 0.49
KDM4E B2RXH2 1/20 0.48
LMNA P02545 1/20 0.48
TP53 P04637 1/20 0.48
MAPT P10636 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30268352 1.00 AKT1 (0.63) AKT1AKT2CYP2A6CYP3A4ALDH1A1
Butylamine SCHEMBL27666227 0.83 CYP3A4 (0.51) AKT1AKT2CYP2A6CYP3A4ALDH1A1
SCHEMBL29636234 0.80
SCHEMBL22636821 0.79 MAPK1 (0.51) AKT1AKT2PIM1MAPK1AURKA
SCHEMBL120088 0.79 CYP2A6 (1.00) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2B6
SCHEMBL30473120 0.79 CYP2A6 (1.00) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2B6
SCHEMBL29419014 0.79 CYP2A6 (1.00) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2B6
SCHEMBL82741 0.78 AKT2 (1.00) AKT1AKT2PIM1METAP2
Benzene SCHEMBL28198087 0.78 AKT2 (1.00) AKT1AKT2PIM1METAP2
SCHEMBL2460206 0.77 CHRNB2 (0.71) ALDH1A1KDM4ETP53MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3294729-A1 SUBSTITUTED QUINOXALINE DERIVATIVES SELVITA S.A. (PL) 2018-03-21 EP claimed
WO-2016180536-A1 SUBSTITUTED QUINOXALINE DERIVATIVES SELVITA S.A. (PL) 2016-11-17 WO claimed
EP-3769763-B1 3-(1H-PYRAZOL-4-YL) PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR MERCK SHARP & DOHME LLC (US) 2025-01-22 EP disclosed
EP-3873467-B1 3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR MERCK SHARP & DOHME LLC (US) 2024-08-28 EP disclosed
CN-114984003-B Aromatic sulfonamide derivatives 拜耳制药股份公司 2024-08-27 CN disclosed
CN-115054600-B Aromatic sulfonamide derivatives 拜耳制药股份公司 2024-06-14 CN disclosed
US-11970479-B2 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor MERCK SHARP & DOHME LLC (US) 2024-04-30 US disclosed
US-20240066033-A1 Compositions and Methods for the Treatment and Diagnosis of Cancer BIOVENTURES, LLC 2024-02-29 US disclosed
US-20240066033-A1 Compositions and Methods for the Treatment and Diagnosis of Cancer BIOVENTURES, LLC 2024-02-29 US disclosed
EP-3644991-B1 3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR MERCK SHARP & DOHME LLC (US) 2023-08-02 EP disclosed
EP-3644992-B1 3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR MERCK SHARP & DOHME LLC (US) 2023-03-29 EP disclosed
WO-2012052412-A1 NOVEL HETEROCYCLIC COMPOUNDS AS PESTICIDES BAYER CROPSCIENCE AG (DE) 2012-04-26 WO disclosed
US-20120094837-A1 Novel Heterocyclic Compounds as Pesticides BAYER CROP SCIENCE AG (DE) 2012-04-19 US disclosed
US-20120094837-A1 Novel Heterocyclic Compounds as Pesticides BAYER CROP SCIENCE AG (DE) 2012-04-19 US disclosed
WO-2012007500-A2 NEW HETEROCYCLIC COMPOUNDS AS PESTICIDES BAYER CROPSCIENCE AG (DE) 2012-01-19 WO disclosed
US-20110166143-A1 Heterocyclic Compounds as Pesticides BAYER CROPSCIENCE AG (DE) 2011-07-07 US disclosed
WO-2011045224-A1 1- (PYRID-3-YL) -PYRAZOLE AND 1- (PYRIMID-5-YL) -PYRAZOLE AS PESTICIDE BAYER CROPSCIENCE AG (DE) 2011-04-21 WO disclosed
CN-1890242-A Pyrazolo and imidazo-pyrimidine derivatives HOFFMANN LA ROCHE (CH) 2007-01-03 CN disclosed
CN-1075965-A New Hete rocyclic derivatives FUJISAWA PHARMACEUTICAL CO (JP) 1993-09-08 CN disclosed
CN-1070404-A New Hete rocyclic derivatives FUJISAWA PHARMACEUTICAL CO (JP) 1993-03-31 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11970479-B2 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor CHRM4, CHRM3, CHRM1 AKT1 4049/4885AKT2 4453/4885CYP2A6 1286/4885
US-20120094837-A1 Novel Heterocyclic Compounds as Pesticides DDT, PTMS, ACHE AKT1 1830/4885AKT2 2680/4885CYP2A6 677/4885
US-20240066033-A1 Compositions and Methods for the Treatment and Diagnosis of Cancer NSUN2, RNMT, TRDMT1 AKT1 2444/4885AKT2 2351/4885CYP2A6 4216/4885
US-20110166143-A1 Heterocyclic Compounds as Pesticides DDT, ACHE, BCHE AKT1 2578/4885AKT2 3033/4885CYP2A6 256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.